Form 8-K - Current report:
SEC Accession No. 0001437749-22-009052
Filing Date
2022-04-15
Accepted
2022-04-15 17:14:54
Documents
15
Period of Report
2022-04-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20220415_8k.htm   iXBRL 8-K 27189
2 EXHIBIT 16.1 ex_359357.htm EX-16.1 904
7 letter01.jpg GRAPHIC 69297
  Complete submission text file 0001437749-22-009052.txt   256258

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20220411.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220411_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220411_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220411_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220415_8k_htm.xml XML 2571
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 22830604
SIC: 2834 Pharmaceutical Preparations